Product Images Simvastatin

This figure shows the effects of treatment with simvastatin on major vascular events and major coronary events in HPS. It presents the baseline incidence of major vascular events and major coronary events among different patient groups (e.g. patients with or without CHD, patients with diabetes mellitus, and patients with peripheral vascular disease). The incidence is compared between simvastatin and placebo groups, with risks ratios and 95% confidence intervals shown. The figure also presents the risk ratios and 95% confidence intervals for major vascular events and major coronary events stratified by gender, age, LDL-cholesterol, and HDL-cholesterol.*

This is a description of a medication containing Simvastatin in tablets of 10 mg. The manufacturer of the medication is Lupin, and the package was created by Vangard in Glasgow, KY with a lot number of 7992. The packaging includes dosage information, storage instructions, and manufacturing information. The medication is intended for institutional use only.*

This text appears to be a list of Simvastatin tablets. It provides information on dosage, lot numbers, and where the packaging was done. However, it is unclear why this information was compiled in this format as there is no other relevant information present.*

This appears to be a label for a package of Simvastatin Tablets, USP. The package contains 30 tablets, each of 20 mg, with lot number 7993. The tablets have been manufactured by Lupin and packaged by Vangard in Glasgow, KY, USA. There is information on storage conditions and a reference to a package insert binder for dosage information.*

This appears to be a label for Simvastatin tablets, USP 20 mg, produced by a company called Vangard based in Glasgow, KY with a LOT number of 7993. The label also contains storage instructions and production details.*